Literature DB >> 24875795

Right heart dysfunction in heart failure with preserved ejection fraction.

Vojtech Melenovsky1, Seok-Jae Hwang2, Grace Lin2, Margaret M Redfield2, Barry A Borlaug2.   

Abstract

AIM: Right heart function is not well characterized in patients with heart failure and preserved ejection fraction (HFpEF). The goal of this study was to examine the haemodynamic, clinical, and prognostic correlates of right ventricular dysfunction (RVD) in HFpEF. METHODS AND
RESULTS: Heart failure and preserved ejection fraction patients (n = 96) and controls (n = 46) underwent right heart catheterization, echocardiographic assessment, and follow-up. Right and left heart filling pressures, pulmonary artery (PA) pressures, and right-sided chamber dimensions were higher in HFpEF compared with controls, while left ventricular size and EF were similar. Right ventricular dysfunction (defined by RV fractional area change, FAC <35%) was present in 33% of HFpEF patients and was associated with more severe symptoms and greater comorbidity burden. Right ventricular function was impaired in HFpEF compared with controls using both load-dependent (FAC: 40 ± 10 vs. 53 ± 7%, P < 0.0001) and load-independent indices (FAC adjusted to PA pressure, P = 0.003), with enhanced afterload-sensitivity compared with controls (steeper FAC vs. PA pressure relationship). In addition to haemodynamic load, RVD in HFpEF was associated with male sex, atrial fibrillation, coronary disease, and greater ventricular interdependence. Over a median follow-up of 529 days (IQR: 143-1066), 31% of HFpEF patients died. In Cox analysis, RVD was the strongest predictor of death (HR: 2.4, 95% CI: 1.6-2.6; P < 0.0001).
CONCLUSION: Right heart dysfunction is common in HFpEF and is caused by both RV contractile impairment and afterload mismatch from pulmonary hypertension. Right ventricular dysfunction in HFpEF develops with increasing PA pressures, atrial fibrillation, male sex, and left ventricular dysfunction, and may represent a novel therapeutic target. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2014. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Gender; Haemodynamics; Heart failure; Pulmonary hypertension; Ventricular function

Mesh:

Year:  2014        PMID: 24875795      PMCID: PMC4425842          DOI: 10.1093/eurheartj/ehu193

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  54 in total

1.  Cardioversion of atrial fibrillation and its effect on right ventricular function as assessed by tricuspid annular motion.

Authors:  M Alam; B A Samad; A Hedman; M Frick; R Nordlander
Journal:  Am J Cardiol       Date:  1999-11-15       Impact factor: 2.778

2.  Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure.

Authors:  Jaroslav Meluzin; Lenka Spinarová; Petr Hude; Jan Krejcí; Vladimír Kincl; Roman Panovský; Ladislav Dusek
Journal:  J Am Soc Echocardiogr       Date:  2005-05       Impact factor: 5.251

Review 3.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

Review 4.  Pulmonary hypertension due to left heart disease.

Authors:  Marco Guazzi; Barry A Borlaug
Journal:  Circulation       Date:  2012-08-21       Impact factor: 29.690

5.  A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.

Authors:  M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

6.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

Review 7.  Right ventricular function in left ventricular disease: pathophysiology and implications.

Authors:  Konstantin Schwarz; Satnam Singh; Dana Dawson; Michael P Frenneaux
Journal:  Heart Lung Circ       Date:  2013-04-12       Impact factor: 2.975

8.  Right atrial size and function assessed with three-dimensional and speckle-tracking echocardiography in 200 healthy volunteers.

Authors:  Diletta Peluso; Luigi P Badano; Denisa Muraru; Lucia Dal Bianco; Umberto Cucchini; Gonenc Kocabay; Attila Kovàcs; Simona Casablanca; Sabino Iliceto
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2013-02-19       Impact factor: 6.875

9.  Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Authors:  Carolyn S P Lam; Peter E Carson; Inder S Anand; Thomas S Rector; Michael Kuskowski; Michel Komajda; Robert S McKelvie; John J McMurray; Michael R Zile; Barry M Massie; Dalane W Kitzman
Journal:  Circ Heart Fail       Date:  2012-08-10       Impact factor: 8.790

10.  Testosterone negatively regulates right ventricular load stress responses in mice.

Authors:  Anna R Hemnes; Karen B Maynard; Hunter C Champion; Linda Gleaves; Niki Penner; James West; John H Newman
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

View more
  160 in total

1.  It is time to look at heart failure with preserved ejection fraction from the right side.

Authors:  Neal A Chatterjee; Johannes Steiner; Gregory D Lewis
Journal:  Circulation       Date:  2014-11-12       Impact factor: 29.690

2.  Pulmonary Hypertension in CKD: Some Answers, Yet More Questions.

Authors:  Mark J Sarnak; Kari E Roberts
Journal:  J Am Soc Nephrol       Date:  2015-09-18       Impact factor: 10.121

3.  The relationship of pulmonary vascular resistance and compliance to pulmonary artery wedge pressure during submaximal exercise in healthy older adults.

Authors:  Stephen P Wright; John T Granton; Sam Esfandiari; Jack M Goodman; Susanna Mak
Journal:  J Physiol       Date:  2016-03-24       Impact factor: 5.182

Review 4.  Pulmonary Hypertension Due to Left Heart Disease: an Update.

Authors:  Mandar A Aras; Mitchell A Psotka; Teresa De Marco
Journal:  Curr Cardiol Rep       Date:  2019-05-27       Impact factor: 2.931

Review 5.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.

Authors:  Sanjiv J Shah; Dalane W Kitzman; Barry A Borlaug; Loek van Heerebeek; Michael R Zile; David A Kass; Walter J Paulus
Journal:  Circulation       Date:  2016-07-05       Impact factor: 29.690

Review 6.  Novel Insights and Treatment Strategies for Right Heart Failure.

Authors:  Weiqin Lin; Ai-Ling Poh; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 7.  Towards Precision in HF Pharmacotherapy.

Authors:  Nicholas B Norgard; Carolyn Hempel
Journal:  Curr Heart Fail Rep       Date:  2017-02

8.  A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction.

Authors:  Yogesh N V Reddy; Rickey E Carter; Masaru Obokata; Margaret M Redfield; Barry A Borlaug
Journal:  Circulation       Date:  2018-08-28       Impact factor: 29.690

9.  Right atrial-right ventricular coupling in heart failure with preserved ejection fraction.

Authors:  Maximilian von Roeder; Johannes Tammo Kowallick; Karl-Philipp Rommel; Stephan Blazek; Christian Besler; Karl Fengler; Joachim Lotz; Gerd Hasenfuß; Christian Lücke; Matthias Gutberlet; Holger Thiele; Andreas Schuster; Philipp Lurz
Journal:  Clin Res Cardiol       Date:  2019-05-03       Impact factor: 5.460

10.  Right Ventricular Function, Right Ventricular-Pulmonary Artery Coupling, and Heart Failure Risk in 4 US Communities: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Kotaro Nochioka; Gabriela Querejeta Roca; Brian Claggett; Tor Biering-Sørensen; Kunihiro Matsushita; Chung-Lieh Hung; Scott D Solomon; Dalane Kitzman; Amil M Shah
Journal:  JAMA Cardiol       Date:  2018-10-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.